Sarah Cannon Research Institute
Maura Mercy is an experienced professional in clinical data operations, currently serving as Manager of Protocol Excellence at Sarah Cannon Research Institute since June 2014, with a progression of roles including Senior Protocol Interpreter and Clinical Trial Specialist. Maura began a career in various positions at The YMCA of Middle Tennessee from May 2008 to June 2014, which included roles as Teen Center Staff and Sports Coach. Additional experience includes event coordination at Gaylord Entertainment and a registrar position at CareSpot. Maura holds a Master of Science in Sustainability with a focus on Sustainable Business Practices from Lipscomb University and a Bachelor of Arts in Music, specializing in Voice Performance from Middle Tennessee State University.
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.